Summary by Moomoo AI
On May 16, 2024, Paul Field, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of common stock at a transaction price of $0.223 per share. Following this transaction, Field's direct holdings in the company increased to a total of 14,000 shares. The transaction, which is categorized as an exercise or conversion of derivative security, reflects Field's investment activity in the company's stock and is part of the insider trading disclosures required by regulatory authorities.